SORL1 and Alzheimer disease: A semiquantitative evaluation of the SORL1 immunoreactivity in the pyramidal neurons in frontal cortex and hippocampus showed that there is a reduction in the two PED.25 affected family members compared to controls (n = 4) and to sporadic AD cases (n = 4).